Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
about
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma.Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.Intraperitoneal hypertension, a novel risk factor for sepsis-associated encephalopathy in sepsis mice.Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resectionRisk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitusEffectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study
P2860
Q40065752-86C7F63A-5A82-46F6-860C-FE4D53601474Q47101714-9AEFC61E-581D-43D5-916A-BDC07832DA4CQ54234628-AD1A2CC8-16E8-45B5-B4BF-B314529BCDBDQ55022752-DD698B05-6D9E-4D47-B98D-4CF31A923876Q55167357-3180954A-674E-4961-8060-69FE4C372596Q55454154-03607EFC-D98B-4DC5-B223-1A018A333CCEQ57071712-1389EB4E-04CE-4526-9B10-3EFA56FDBE89Q58739563-2B72A886-8463-4454-85AA-AA699100A674Q58802114-69EA23FF-5465-422E-AB83-34824EA0DF41
P2860
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Effectiveness of entecavir or ...... ith entecavir and telbivudine.
@en
type
label
Effectiveness of entecavir or ...... ith entecavir and telbivudine.
@en
prefLabel
Effectiveness of entecavir or ...... ith entecavir and telbivudine.
@en
P2093
P2860
P1433
P1476
Effectiveness of entecavir or ...... with entecavir and telbivudine
@en
P2093
P2860
P356
10.1097/MD.0000000000007021
P407
P50
P577
2017-06-01T00:00:00Z